-
Nippon India Pharma IDCW-P
Equity healthcare
Overview ( as on 21/03/25 )
NAV
₹114.03
Last change
₹0.78 +0.01%
Fund Size (AUM)
7637.04 Cr
Performance
30.91% (5Y)
Fund Details
Nippon India Pharma IDCW-P
as of 21/03/25
AUM
7637.04 Cr
Expense Ratio
1.82 %
Benchmark
BSE Healthcare TR INR
ISIN
INF204K01935
Fund Manager
Sailesh Raj Bhan
Exit Load
1.0% if redeemed within 0-1 months
0% if redeemed after 1 months
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| Nippon India Pharma IDCW-P | 15.58% | 18.64% | 30.91% |
| BSE Healthcare TR INR | 8.93% | 17.83% | 23.17% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
13.68% |
Divi's Laboratories Ltd |
9.32% |
Lupin Ltd |
7.73% |
Cipla Ltd |
5.9% |
Dr Reddy's Laboratories Ltd |
5.35% |
Apollo Hospitals Enterprise Ltd |
5.14% |
Abbott India Ltd |
3.82% |
Vijaya Diagnostic Centre Ltd |
3.41% |
Medplus Health Services Ltd |
3.39% |
GlaxoSmithKline Pharmaceuticals Ltd |
3.28% |
Sector Allocation
Healthcare |
100.0% |
Asset Allocation
-
99%
Equity
-
1%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Gr
Equity healthcare-
Returns
-
31.02% (5Y)
-
-
SBI Healthcare Opportunities Reg Gr
Equity healthcare-
Returns
-
30.13% (5Y)
-
-
SBI Healthcare Opportunities Reg IDCW-R
Equity healthcare-
Returns
-
30.14% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
28.15% (5Y)
-
-
DSP Healthcare Fund Reg Gr
Equity healthcare-
Returns
-
29.32% (5Y)
-
-
UTI Healthcare Reg Gr
Equity healthcare-
Returns
-
27.8% (5Y)
-
